Addison Disease
Addison disease (primary adrenal insufficiency) is chronic damage and failure of the entire adrenal cortex, most often autoimmune (80–90% of cases) but also caused by infections such as tuberculosis, or by hemorrhage or metastases. The severe shortfall of two vital hormones, cortisol and aldosterone, not only puts patients at risk of life-threatening adrenal crises but also produces characteristic color changes in the skin and mucous membranes. Diffuse skin darkening together with pigmentation inside the mouth is often the earliest clinical clue that allows a dermatologist to diagnose Addison disease before dangerous endocrine symptoms appear.
How the skin darkens:
- Loss of HPA Axis Feedback and the POMC Precursor: In Addison disease, low blood cortisol removes the negative feedback on the pituitary and hypothalamus. The hypothalamus releases more CRH, which drives the pituitary to produce large amounts of the precursor pro-opiomelanocortin (POMC).
- POMC Cleavage and MC1R Stimulation: Convertase enzymes in the pituitary split POMC into adrenocorticotropic hormone (ACTH) and alpha-melanocyte-stimulating hormone (alpha-MSH). Blood levels of ACTH and alpha-MSH can climb to dozens of times normal.
- Increased Eumelanin in the Basal Epidermis: Both ACTH and alpha-MSH bind directly to the melanocortin-1 receptor (MC1R) on melanocytes in the basal layer. This switches on the cAMP–PKA–MITF pathway, increases tyrosinase and triggers a surge in eumelanin (black/brown pigment) production.
- Characteristic Distribution: Eumelanin production rises throughout the body but is most visible on sun-exposed skin, areas of friction or pressure (palmar creases, elbows, chest, armpits) and especially the lining of the mouth, where melanocytes are stimulated by the minor trauma of eating.
Skin and Mucosal Signs of Addison Disease
Patients with Addison disease show pigmentary and hormone-related signs that point strongly to the diagnosis:
- Generalized Hyperpigmentation:
- The skin turns bronze, grayish-brown or dark brown all over, looking like a suntan that never fades, all year round.
- The darkening is most intense on exposed skin (face, neck, backs of the hands) and areas of friction: palmar creases, elbows, knees, the waistband line, the areolae and the genitals.
- Recent scars: Scars that form after Addison disease begins become noticeably dark, while older scars may be unaffected.
- Mucosal Hyperpigmentation (A Characteristic Sign): Large blue-gray or dark brown patches and spots appear on the inner cheeks (buccal mucosa), gums, tongue, palate and lips. Mucosal pigmentation is the key feature that distinguishes primary adrenal insufficiency (Addison disease) from secondary adrenal insufficiency.
- Associated Autoimmune Depigmentation (Vitiligo): About 10–20% of patients with autoimmune Addison disease also have vitiligo, as part of autoimmune polyglandular syndrome type 1 or 2 (APS-1 or APS-2). Stark white patches appear against the background of bronze, hyperpigmented skin.
- Hair Changes in Women: Women may lose some or all of their underarm and pubic hair because the failing adrenal cortex makes less androgen (mainly DHEA).
Addison Hyperpigmentation vs. Secondary Adrenal Insufficiency vs. Melasma/PIH
| Addison Disease (Primary Adrenal Insufficiency) | Secondary Adrenal Insufficiency (Pituitary/Steroid-Related) | Melasma / Post-Inflammatory Hyperpigmentation (PIH) |
|---|---|---|
| ACTH very high (> 100 pg/mL) | ACTH low or undetectable | ACTH normal |
| Hyperpigmented: diffuse bronze color, most marked in creases and friction areas | No hyperpigmentation: pale, washed-out skin due to low ACTH | Pigment mainly on the face or at sites of previous skin injury |
| Dark patches on the oral mucosa and gums | None | None |
| Loss of underarm/pubic hair | Possible loss of underarm/pubic hair | No loss of underarm/pubic hair |
| Orthostatic hypotension, weight loss, salt craving, low blood sugar | Symptoms of multiple pituitary hormone deficiencies or related to long-term steroid use | No systemic symptoms |
Our Approach
At Haute-Derma, patients with hyperpigmentation suspicious for Addison disease are assessed through a standardized, comprehensive diagnostic pathway:
- Screening for Systemic Symptoms and Medical History:
- A careful review for signs of physical decline: unexplained chronic fatigue, rapid weight loss, poor appetite, salt craving, nausea and low blood pressure on standing.
- A check for other autoimmune conditions (Hashimoto thyroiditis, type 1 diabetes, vitiligo, celiac disease).
- Assessing the Location and Pattern of Skin and Mucosal Pigmentation:
- A full skin examination focusing on the palmar creases, elbows and any recent scars.
- A mandatory look inside the mouth (inner cheeks, gums, palate) for the characteristic blue-gray patches.
- Endocrine Testing:
- 8 a.m. serum cortisol: A level below 3 µg/dL strongly suggests adrenal insufficiency.
- Serum ACTH: A markedly raised ACTH (> 100 pg/mL) confirms that the problem lies in the adrenal cortex itself (Addison disease).
- Electrolytes: Checking for low sodium (hyponatremia) and high potassium (hyperkalemia).
- Pigment Analysis With Dermoscopy: Dermoscopy is used to assess how eumelanin is distributed around follicular openings and along the basement membrane, and to distinguish it from heavy-metal deposits or drug-induced pigmentation (such as from minocycline or amiodarone).
Treatment at Haute-Derma
Our plan for managing and restoring skin color in Addison disease combines treatment of the underlying hormone deficiency with gentle cosmetic care:
- Hormone Replacement for the Root Cause:
- Patients must be referred to, and followed jointly with, an endocrinologist for lifelong hormone replacement: hydrocortisone (or prednisolone) to replace glucocorticoids and fludrocortisone to replace mineralocorticoids.
- Bringing cortisol back to physiological levels restores feedback, gradually lowers ACTH and alpha-MSH to normal, and sharply reduces the signal driving the melanocytes.
- Topical Pigment Control and Repair:
- Gentle tyrosinase inhibitors: Topical azelaic acid 15%, niacinamide 5%, tranexamic acid 3–5% or alpha arbutin help clear residual eumelanin from the keratinocytes more quickly.
- Broad-spectrum sun protection: A broad-spectrum mineral sunscreen (zinc oxide, titanium dioxide) that blocks UVA, UVB and visible (HEV) light keeps sunlight from re-stimulating the melanocytes.
- Managing Coexisting Vitiligo (If Present): Once adrenal hormone levels are stable, depigmented patches from associated autoimmune vitiligo are treated with a topical calcineurin inhibitor (tacrolimus 0.1%) combined with narrowband UVB phototherapy to stimulate melanocyte regrowth from the edges of the white patches.
